FindTrial
Sign In

Screening and validation of novel markers of adverse pregnancy outcomes in women with hyperglycemia during pregnancy

Screening and validation of novel markers of adverse pregnancy outcomes in women with hyperglycemia during pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099369
Enrollment
Unknown
Registered
2025-03-21
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperglycemia during pregnancy

Interventions

Adverse Pregnancy Outcomes Group in Hyperglycemia in Pregnancy (HIP):None
Control Group:None

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Age >= 18 years; delivery of a live birth or stillbirth at 24 weeks or later; absence of congenital malformations; singleton pregnancy.

Exclusion criteria

Exclusion criteria: Pregnancies with aneuploidy or major fetal abnormalities; individuals with ocular diseases such as cataracts, glaucoma, or severe refractive media opacities; those with chronic hypertension, systemic lupus erythematosus, antiphospholipid antibody syndrome, kidney disease, hepatitis, etc.; inability to track pregnancy outcomes.

Design outcomes

Primary

MeasureTime frame
multi-omics data;CGM parameters;ocular biological parameters;—

Countries

China

Contacts

Public ContactWang Zilian

The First Affiliated Hospital of Sun Yat-sen University

wangzil@mail.sysu.edu.cn+86 136 0288 5248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026